The dynamic regulating role of SE-driven oncogenic lncRNA-HSAL3 in HCC, which can be a potential target for inhibiting HCC progression (Yuan et al., 2023). This evidence concerns the gene HEXIM2-AS2 and hepatocellular carcinoma.